LRRK2 and Parkinson disease: In a human study, both asymptomatic and PD patient carriers of LRRK2 G2019S mutation showed increased levels of peripheral inflammatory cytokines [43], suggesting a pathological contribution of LRRK2 mutations in mediating peripheral immune response.